Related Experiment Video
Updated: Jan 18, 2026

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
Imaging spatial transcriptomics reveals molecular patterns underlying accumulation of p-Ser129 α-synuclein in a
Liam Horan-Portelance1, Michiyo Iba1, Dominic J Acri1
1Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Researchers identified specific neuron types vulnerable to alpha-synuclein buildup in a Parkinson's disease mouse model. This vulnerability is linked to Plk2 and human SNCA gene expression, impacting mitochondrial and endolysosomal pathways.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Parkinson's disease and dementia with Lewy bodies involve aggregated, phosphorylated alpha-synuclein (α-synuclein) in specific neurons.
- The reasons behind selective neuronal vulnerability in synucleinopathies remain largely unknown.
Purpose of the Study:
- To identify neuronal subtypes vulnerable to α-synuclein phosphorylation in a mouse model.
- To investigate the transcriptional factors contributing to this selective vulnerability.
- To explore downstream gene expression changes associated with α-synuclein pathology.
Main Methods:
- Imaging spatial transcriptomics (IST) combined with immunofluorescence for phosphorylated α-synuclein (pSyn).
- Analysis of transgenic mice overexpressing human α-synuclein (hSNCA).
- Differential gene expression analysis.
Main Results:
- Identified specific neuronal subtypes in the cortex and hippocampus with preferential pSyn accumulation.
- Highlighted the role of Plk2 and hSNCA expression in pSyn development.
- Revealed broad gene expression changes downstream of hSNCA and pSyn, including alterations in mitochondrial and endolysosomal genes.
Conclusions:
- This study provides novel insights into the mechanisms of phospho-α-synuclein formation and its consequences.
- Identified key molecular players (Plk2, hSNCA) contributing to selective neuronal vulnerability in a synucleinopathy model.
- Demonstrated pSyn-dependent effects on cellular pathways, offering potential therapeutic targets.
More Related Videos
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
09:32Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
Published on: April 13, 2017